Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_4
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
3(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Terminated(1)
Other(2)

Detailed Status

unknown2
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 43 (100.0%)

Trials by Status

completed125%
unknown250%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
completed

Observational Study of Oxygen Delivery During a Fractional Fluid Expansion

NCT01826253
unknownphase_4

ED50 Determination of Hydroxyethylstarch for Treatment of Hypotension During Cesarean Section Under Spinal Anesthesia

NCT01415284
unknownphase_4

Fluid Infusion During Breast Surgery

NCT00431743
terminatedphase_4

Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver Transplantation

NCT00308100

Clinical Trials (4)

Showing 4 of 4 trials
NCT01826253

Observational Study of Oxygen Delivery During a Fractional Fluid Expansion

Completed
NCT01415284Phase 4

ED50 Determination of Hydroxyethylstarch for Treatment of Hypotension During Cesarean Section Under Spinal Anesthesia

Unknown
NCT00431743Phase 4

Fluid Infusion During Breast Surgery

Unknown
NCT00308100Phase 4

Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver Transplantation

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4